Lan Xiao

1.7k total citations
34 papers, 1.3k citations indexed

About

Lan Xiao is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Lan Xiao has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Lan Xiao's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Lan Xiao is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Lan Xiao collaborates with scholars based in China, United States and Australia. Lan Xiao's co-authors include John A. Spertus, Frederick A. Masoudi, Philip G. Jones, Silvio E. Inzucchi, Mikhail Kosiborod, Harlan M. Krumholz, Steven P. Marso, Suzanne Fiske, Zhimin Li and Zehua Wang and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Biochemical Journal.

In The Last Decade

Lan Xiao

33 papers receiving 1.3k citations

Peers

Lan Xiao

EDM

CCM

EPIDE

Jun Morinaga Japan

Sharon Li Ting Pek Singapore

Chengchun Tang China

Gaoliang Yan China

Akira Shouzu Japan

Zhanmei Zhou China

Hiroyasu Uzui Japan

Joel Thompson United States

Hüseyin Altuğ Çakmak Türkiye

Kateřina Kaňková Czechia

Jun Morinaga Japan

Lan Xiao

374 ×0.7

254 ×0.6

144 ×0.5

EDM

307 ×1.2

CCM

105 ×0.8

EPIDE

Citations per year, relative to Lan Xiao Lan Xiao (= 1×) peers Jun Morinaga

Countries citing papers authored by Lan Xiao

Since Specialization

Citations

This map shows the geographic impact of Lan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Xiao more than expected).

Fields of papers citing papers by Lan Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Xiao. The network helps show where Lan Xiao may publish in the future.

Co-authorship network of co-authors of Lan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Xiao. A scholar is included among the top collaborators of Lan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Xiao. Lan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ruiyun, Tingxi Yu, Hee Kyoung Chung, et al.. (2024). miR‐495 promotes intestinal epithelial cell apoptosis through downregulation of Sphingosine‐1‐phosphate. Physiological Reports. 12(17). e70021–e70021.

Chen, Cheng, et al.. (2024). Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis. Gynecologic and Obstetric Investigation. 89(5). 363–375. 2 indexed citations

Sun, Lei, et al.. (2023). The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells. Journal of Ovarian Research. 16(1). 187–187. 3 indexed citations

Li, Kuokuo, et al.. (2023). Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center. BMC Cancer. 23(1). 489–489. 3 indexed citations

Chen, Juan, et al.. (2022). Better or worse? The prognostic role of the mesenchymal subtype in patients with high‐grade serous ovarian carcinoma: A systematic review and meta‐analysis. Cancer Medicine. 11(20). 3761–3770. 2 indexed citations

Xiao, Lan, et al.. (2022). Perioperative Ischemic Optic Neuropathy after Cardiac Surgery: Development and Validation of a Preoperative Risk Prediction Model. Journal of Cardiothoracic and Vascular Anesthesia. 36(12). 4266–4272. 2 indexed citations

Xiao, Lan, et al.. (2021). Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway. Journal of Gynecologic Oncology. 32(5). e77–e77. 28 indexed citations

Moss, Heather E., et al.. (2020). Perioperative ischemic optic neuropathy in spinal fusion surgery: validating a predictive scoring system. The Spine Journal. 20(10). 1527–1528. 3 indexed citations

Moss, Heather E., et al.. (2020). Predictive model of ischemic optic neuropathy in spinal fusion surgery using a longitudinal medical claims database. The Spine Journal. 21(3). 377–386. 5 indexed citations

10.

Cao, Shan, Lan Xiao, Junyao Wang, Guodong Chen, & Yulan Liu. (2020). The RNA-binding protein HuR regulates intestinal epithelial restitution by modulating Caveolin-1 gene expression. Biochemical Journal. 478(1). 247–260. 5 indexed citations

11.

Shi, Xiaoyan, et al.. (2019). Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer. BMC Molecular and Cell Biology. 20(1). 49–49. 35 indexed citations

12.

Shi, Xiaoyan, Lan Xiao, Jinrong He, et al.. (2018). miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells. Frontiers in Genetics. 9. 555–555. 40 indexed citations

13.

Stolker, Joshua M., Peter A. McCullough, Silvio E. Inzucchi, et al.. (2010). Pre-Procedural Glucose Levels and the Risk for Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography. Journal of the American College of Cardiology. 55(14). 1433–1440. 76 indexed citations

14.

Li, Zhimin, Sha Hu, Jing Wang, et al.. (2010). MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecologic Oncology. 119(1). 125–130. 160 indexed citations

15.

Amin, Amit P., John A. Spertus, Kimberly J. Reid, et al.. (2010). The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. American Heart Journal. 160(6). 1065–1071. 101 indexed citations

16.

Arnold, Suzanne V., John A. Spertus, Philip G. Jones, Lan Xiao, & David J. Cohen. (2009). The impact of dyspnea on health-related quality of life in patients with coronary artery disease: Results from the PREMIER registry. American Heart Journal. 157(6). 1042–1049.e1. 47 indexed citations

17.

Zhou, Yanhong, Zhaoyang Zeng, Wenling Zhang, et al.. (2008). Lactotransferrin: A candidate tumor suppressor—Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen‐activated protein kinase pathway. International Journal of Cancer. 123(9). 2065–2072. 96 indexed citations

18.

Morgan, Thomas M., et al.. (2008). Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome. BMC Medical Genetics. 9(1). 66–66. 15 indexed citations

19.

Xiao, Lan, et al.. (2007). Orbital schwannomas: findings from magnetic resonance imaging in 62 cases. Eye. 22(8). 1034–1039. 51 indexed citations

20.

Xiao, Lan, et al.. (2007). The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(6). 725–728. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact